Intelligence · Patents
Patents expiring in 2040
Annual patent cliff calendar for 2040 — US pharmaceutical patents by expiration date.
- Patents
- 1,866
Quick answer
1,866 indexed pharmaceutical patents have expiration dates in 2040. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 10668050
Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome
granted -
US 10668114
Use of gram negative species to treat atopic dermatitis
granted -
US 10668170
Modified RNAi agents
granted -
US 10669242
Clostridium difficile toxin inhibitors
granted -
US 10668279
Miniminally invasive dermal electroporation device
granted -
US 10669303
Compositions and methods directed to treating liver fibrosis
granted -
US 10668118
Microbial consortium and uses thereof
granted -
US 10668260
Microneedle patch
granted -
US 10669320
Mps1 and KNL1 phosphorylation system
granted -
US 10669311
Targeted delivery system and methods of use therefor
granted -
US 10669544
Therapeutic compositions
granted -
US 10669337
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same
granted -
US 10668171
Methods for modulating RNA splicing
granted -
US 10669312
Peptide for suppressing osteoclast differentiation and use thereof
granted -
US 10669560
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10668127
Method and composition for synchronizing time of insemination
granted -
US 10669347
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
granted -
US 10669298
Mannose derivatives for treating bacterial infections
granted -
US 10668129
Synergistic combination of neuronal viability factors and uses thereof
granted -
US 10668107
Methods of transdifferentiation and methods of use thereof
granted -
US 10668049
Methods of treating cognitive decline with transforming growth factor beta inhibitors
granted -
US 10668015
Unit aerosol doses for anticoagulation
granted -
US 10668002
Anhydrous polysaccharide films
granted -
US 10668055
Cancer treatment using combinations of ERK and RAF inhibitors
granted -
US 10668062
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
granted -
US 10668161
Therapeutic hyperbranched polyglycerol encapsulated biomolecules
granted -
US 10669339
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 10667994
Bioactive dental restorative material with remineralization properties
granted -
US 10668021
Metformin hydrochloride osmotic pump tablet and preparation method therefor
granted -
US 10669516
Methods and apparatus for conditioning cell populations for cell therapies
granted -
CA 3121191
CAS9 DE CODAGE D'ARNM OPTIMISE DESTINE A ETRE UTILISE DANS DES LNP
granted -
US 10675308
Chinese medicine extract and preparation method and application thereof
granted -
US 10675246
Orally administrable compositions comprising calcium
granted -
US 10675245
Sustained release formulation of a non-steroidal anti-inflammatory drug
granted -
US 10676530
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
granted -
US 10675358
Antibody adjuvant conjugates
granted -
US 10676474
1,6-naphthyridine derivatives as CDK4/6 inhibitor
granted -
US 10675341
Parenteral norovirus vaccine formulations
granted -
US 10675304
Combination immunotherapies for treatment of cancer
granted -
US 10675288
Natural combination hormone replacement formulations and therapies
granted -
US 10675258
Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
granted -
US 10675272
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted -
US 10674901
Minimally-invasive measurement of esophageal inflammation
granted -
US 10675273
Benzothiazole amphiphiles
granted -
US 10675271
Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy
granted -
US 10675283
Compositions and methods for white to beige adipogenesis
granted -
US 10677801
Diagnosis and treatment of breast cancer
granted -
US 10675267
Methods for detection and eradication of myeloid leukemia stem cells
granted
Frequently asked questions
How many pharma patents expire in 2040?
1,866 published patents in our USPTO index have expiration dates falling in calendar year 2040.